Global Paclitaxel Industry Research Report, Growth Trends and Competitive Analysis 2021-2027

Report Description


The Global Paclitaxel Market Report provides Insightful information to the clients enhancing their basic leadership capacity identified with the global Paclitaxel Market business, including market dynamics, segmentation, competition, and regional growth. The strategy of expansion has been adopted by key players who are increasing their production capacities to cater to the increasing demand for various application.

New traders at intervals the Paclitaxel Market face strong competition from ancient world traders as they try with technological revolutions, dependableness and commonplace of Paclitaxel Market product affairs. The report is at risk of project regarding this Paclitaxel Market evolutions and additionally the magnitude of competition, value and extra.

Leading market players: (Option 1: Free 25% Customization Profiles of 5 Additional Companies of your Choice)


This business intelligence report offers profiling of reputed companies that are operating in the market. Companies such as:

  • Phyton
  • ScinoPharm
  • Novasep
  • Samyang
  • Polymed
  • TAPI (Teva)
  • Fresenius-kabi
  • Huiang biopharma
  • Southpharma
  • Yunnan Hande
  • Hainan Yew Pharm
  • Jiangsu Yew Biotechnology

Others players have been profiled into detail so as to offer a glimpse of the market leaders. Moreover, parameters such as Paclitaxel related investment & spending and developments by major players of the market are tracked in this Global report.

Years considered for the study:


Paclitaxel Market

Paclitaxel Market

Report Highlights:


The Paclitaxel Market is widely partitioned reliant on the predictable updates in the enhancement of parameters for example, quality, trustworthiness, end customer solicitations, applications, and others. The Paclitaxel Market report contains general successful parameters, confinements, and besides has in detail illumination of the noteworthy data close by the present and future examples that may concern the advancement. The comprehensive Paclitaxel Market report elucidates within and outside representation of current advancements, parameters, and establishments.

The key regions analyzed in this study include North America, Europe, Japan, China, India, Korea, South East Asia, South America, Middle East and African countries. The leading players of Paclitaxel Market and their geographical presence across the globe are estimated based on production capacity, utilization ratio, consumer base, demand and supply scenario, profit margin and Paclitaxel marketers.

Data Lab Forecast performed primary as well as exhaustive secondary research for this study. We conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, DLF was able to include manufacturers that could not be identified due to the limitations of secondary research. We analysed product offerings, distribution channel and regional presence of all major companies in the industry.

Data Lab Forecast calculated the market size for the Paclitaxel market using a bottom-up approach, wherein manufacturers value data for different type (Natural Paclitaxel API, Semi-synthetic Paclitaxel API), of Paclitaxel market was recorded as well as forecast for the future years was made. Data Lab Forecast sourced these values from industry experts and company representatives, and externally validated through analyzing historical sales data of respective manufacturers to arrive at the overall market size. Various secondary sources such as company annual reports, white papers, investor presentations and financial reports were also studied by Data Lab Forecast.

Paclitaxel Market

Paclitaxel Market

Key Target Audience:


  • Paclitaxel market companies.
  • Research organizations and consulting companies.
  • Organizations, associations and alliances related to the Paclitaxel market industry.
  • Government bodies such as regulating authorities and policymakers.
  • Industry associations.

The study is useful in providing answers to several critical questions that are important for industry stakeholders, such as manufacturers, distributors, dealers and policymakers, about which market segments should be targeted over retail cosmetics outlets in coming years to strategize investments and capitalize on growth of the market.

Report Scope:


In this report, Paclitaxel market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

In terms of type, the Global Paclitaxel market is segregated into:


The report includes in-detail references of all the notable product categories as well as application specifications. The product segment is described on the basis of key player development traits, sales overview, volume based returns and the like.

  • Natural Paclitaxel API
  • Semi-synthetic Paclitaxel API

By end-user also classify into, the Global Paclitaxel market:


Global Paclitaxel market also specifically underpins end-use application scope and their improvements based on technological developments and consumer preferences.

  • Ovarian Cancer
  • Cervical Cancer
  • Breast Cancer
  • Other

Highlights of this 2021-2027 Paclitaxel Market Report:

  • Market dynamics, Paclitaxel economy manufacturing, opportunities on the total pricing of this top manufacturer and improvement trend analysis;
  • Paclitaxel industry players at the general regional industry and economy synopsis;
  • Deep analysis of the most significant market players included by Worldwide Paclitaxel Market study report;
  • Understand more about the market plans that are increasingly now being adopted by leading Paclitaxel businesses;
  • Evaluation of this market character, namely market development drivers, essential challengers, inhibitors, and chances;
  • Strategically profile the key players and comprehensively analyze their growth strategies.

Competitive Landscape:

Company Profiles: Detailed analysis of the major companies presents in the Paclitaxel market.

Product Benchmarking: Benchmarking of most selling variant of all leading companies based on product type. In-depth analysis of benchmarking and recommendation on ideal product specifications.

Voice of Customer: Customer analysis by considering the major factors influencing the purchasing decision.

Available Customizations:

With the given market data, Data Lab Forecast offers customizations according to the companys specific needs. The following customization options are available for the report:

Channel Partner Analysis: Detailed list of distributors and dealers across the country.

Company Information: Detailed analysis and profiling of additional market players (up to five).

Product Information: Detailed analysis of new products in the market and their driving forces in the market.

In case you dont find what you are looking for, please get in touch with our custom research team at sales@datalabforecast.com

TableofContents 1ReportOverview 1.1ResearchScope 1.2TopPaclitaxelManufacturersCovered:RankingbyRevenue 1.3MarketSegmentbyType 1.3.1GlobalPaclitaxelMarketSizebyType:2016VS2021VS2027(US$Million) 1.3.2NaturalPaclitaxelAPI 1.3.3Semi-syntheticPaclitaxelAPI 1.4MarketSegmentbyApplication 1.4.1GlobalPaclitaxelConsumptionbyApplication:2016VS2021VS2027 1.4.2OvarianCancer 1.4.3CervicalCancer 1.4.4BreastCancer 1.4.5Other 1.5StudyObjectives 1.6YearsConsidered 2GlobalMarketPerspective 2.1GlobalPaclitaxelRevenue(2016-2027) 2.1.1GlobalPaclitaxelRevenue(2016-2027) 2.1.2GlobalPaclitaxelSales(2016-2027) 2.2PaclitaxelMarketSizeacrossKeyGeographiesWorldwide:2016VS2021VS2027 2.2.1GlobalPaclitaxelSalesbyRegions(2016-2021) 2.2.2GlobalPaclitaxelRevenuebyRegions(2016-2021) 2.3GlobalTopPaclitaxelRegions(Countries)RankingbyMarketSize 2.4PaclitaxelIndustryTrends 2.4.1PaclitaxelMarketTopTrends 2.4.2MarketDrivers 2.4.3PaclitaxelMarketChallenges 2.4.4PortersFiveForcesAnalysis 2.4.5PrimaryInterviewswithKeyPaclitaxelPlayers:ViewsforFuture 3CompetitiveLandscapebyManufacturers 3.1GlobalTopPaclitaxelManufacturersbySales(2016-2021) 3.1.1GlobalPaclitaxelSalesbyManufacturers(2016-2021) 3.1.2GlobalPaclitaxelSalesMarketSharebyManufacturers(2016-2021) 3.1.3Global5and10LargestManufacturersbyPaclitaxelSalesin2020 3.2GlobalTopManufacturersPaclitaxelbyRevenue 3.2.1GlobalPaclitaxelRevenuebyManufacturers(2016-2021) 3.2.2GlobalPaclitaxelRevenueSharebyManufacturers(2016-2021) 3.2.3GlobalPaclitaxelMarketConcentrationRatio(CR5andHHI) 3.3GlobalTopManufacturersbyCompanyType(Tier1,Tier2andTier3)(basedontheRevenueinPaclitaxelasof2020) 3.4GlobalPaclitaxelAverageSellingPrice(ASP)byManufacturers 3.5KeyManufacturersPaclitaxelPlants/FactoriesDistributionandAreaServed 3.6DateofKeyManufacturersEnterintoPaclitaxelMarket 3.7KeyManufacturersPaclitaxelProductOffered 3.8Mergers&Acquisitions,ExpansionPlans 4MarketSizebyType 4.1GlobalPaclitaxelHistoricMarketReviewbyType(2016-2021) 4.1.2GlobalPaclitaxelSalesMarketSharebyType(2016-2021) 4.1.3GlobalPaclitaxelRevenueMarketSharebyType(2016-2021) 4.1.4PaclitaxelPricebyType(2016-2021) 4.1GlobalPaclitaxelMarketEstimatesandForecastsbyType(2021-2027) 4.2.2GlobalPaclitaxelSalesForecastbyType(2021-2027) 4.2.3GlobalPaclitaxelRevenueForecastbyType(2021-2027) 4.2.4PaclitaxelPriceForecastbyType(2021-2027) 5GlobalPaclitaxelMarketSizebyApplication 5.1GlobalPaclitaxelHistoricMarketReviewbyApplication(2016-2021) 5.1.2GlobalPaclitaxelSalesMarketSharebyApplication(2016-2021) 5.1.3GlobalPaclitaxelRevenueMarketSharebyApplication(2016-2021) 5.1.4PaclitaxelPricebyApplication(2016-2021) 5.2GlobalPaclitaxelMarketEstimatesandForecastsbyApplication(2021-2027) 5.2.2GlobalPaclitaxelSalesForecastbyApplication(2021-2027) 5.2.3GlobalPaclitaxelRevenueForecastbyApplication(2021-2027) 5.2.4PaclitaxelPriceForecastbyApplication(2021-2027) 6NorthAmerica 6.1NorthAmericaPaclitaxelBreakdownDatabyCompany 6.2NorthAmericaPaclitaxelBreakdownDatabyType 6.3NorthAmericaPaclitaxelBreakdownDatabyApplication 6.4NorthAmericaPaclitaxelBreakdownDatabyCountries 6.4.1NorthAmericaPaclitaxelSalesbyCountries 6.4.2NorthAmericaPaclitaxelRevenuebyCountries 6.4.3U.S. 6.4.4Canada 7Europe 7.1EuropePaclitaxelBreakdownDatabyCompany 7.2EuropePaclitaxelBreakdownDatabyType 7.3EuropePaclitaxelBreakdownDatabyApplication 7.4EuropePaclitaxelBreakdownDatabyCountries 7.4.1EuropePaclitaxelSalesbyCountries 7.4.2EuropePaclitaxelRevenuebyCountries 7.4.3Germany 7.4.4France 7.4.5U.K. 7.4.6Italy 7.4.7Russia 8AsiaPacific 8.1AsiaPacificPaclitaxelBreakdownDatabyCompany 8.2AsiaPacificPaclitaxelBreakdownDatabyType 8.3AsiaPacificPaclitaxelBreakdownDatabyApplication 8.4AsiaPacificPaclitaxelBreakdownDatabyRegions 8.4.1AsiaPacificPaclitaxelSalesbyRegions 8.4.2AsiaPacificPaclitaxelRevenuebyRegions 8.4.3China 8.4.4Japan 8.4.5SouthKorea 8.4.6India 8.4.7Australia 8.4.8Taiwan 8.4.9Indonesia 8.4.10Thailand 8.4.11Malaysia 8.4.12Philippines 8.4.13Vietnam 9LatinAmerica 9.1LatinAmericaPaclitaxelBreakdownDatabyCompany 9.2LatinAmericaPaclitaxelBreakdownDatabyType 9.3LatinAmericaPaclitaxelBreakdownDatabyApplication 9.4LatinAmericaPaclitaxelBreakdownDatabyCountries 9.4.1LatinAmericaPaclitaxelSalesbyCountries 9.4.2LatinAmericaPaclitaxelRevenuebyCountries 9.4.3Mexico 9.4.4Brazil 9.4.5Argentina 10MiddleEastandAfrica 10.1MiddleEastandAfricaPaclitaxelBreakdownDatabyType 10.2MiddleEastandAfricaPaclitaxelBreakdownDatabyApplication 10.3MiddleEastandAfricaPaclitaxelBreakdownDatabyCountries 10.3.1MiddleEastandAfricaPaclitaxelSalesbyCountries 10.3.2MiddleEastandAfricaPaclitaxelRevenuebyCountries 10.3.3Turkey 10.3.4SaudiArabia 10.3.5U.A.E 11CompanyProfiles 11.1Phyton 11.1.1PhytonCorporationInformation 11.1.2PhytonBusinessOverviewandTotalRevenue(2020VS2018) 11.1.3PhytonPaclitaxelSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021) 11.1.4PhytonPaclitaxelProductsandServices 11.1.5PhytonSWOTAnalysis 11.1.6PhytonRecentDevelopments 11.2ScinoPharm 11.2.1ScinoPharmCorporationInformation 11.2.2ScinoPharmBusinessOverviewandTotalRevenue(2020VS2018) 11.2.3ScinoPharmPaclitaxelSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021) 11.2.4ScinoPharmPaclitaxelProductsandServices 11.2.5ScinoPharmSWOTAnalysis 11.2.6ScinoPharmRecentDevelopments 11.3Novasep 11.3.1NovasepCorporationInformation 11.3.2NovasepBusinessOverviewandTotalRevenue(2020VS2018) 11.3.3NovasepPaclitaxelSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021) 11.3.4NovasepPaclitaxelProductsandServices 11.3.5NovasepSWOTAnalysis 11.3.6NovasepRecentDevelopments 11.4Samyang 11.4.1SamyangCorporationInformation 11.4.2SamyangBusinessOverviewandTotalRevenue(2020VS2018) 11.4.3SamyangPaclitaxelSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021) 11.4.4SamyangPaclitaxelProductsandServices 11.4.5SamyangSWOTAnalysis 11.4.6SamyangRecentDevelopments 11.5Polymed 11.5.1PolymedCorporationInformation 11.5.2PolymedBusinessOverviewandTotalRevenue(2020VS2018) 11.5.3PolymedPaclitaxelSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021) 11.5.4PolymedPaclitaxelProductsandServices 11.5.5PolymedSWOTAnalysis 11.5.6PolymedRecentDevelopments 11.6TAPI(Teva) 11.6.1TAPI(Teva)CorporationInformation 11.6.2TAPI(Teva)BusinessOverviewandTotalRevenue(2020VS2018) 11.6.3TAPI(Teva)PaclitaxelSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021) 11.6.4TAPI(Teva)PaclitaxelProductsandServices 11.6.5TAPI(Teva)SWOTAnalysis 11.6.6TAPI(Teva)RecentDevelopments 11.7Fresenius-kabi 11.7.1Fresenius-kabiCorporationInformation 11.7.2Fresenius-kabiBusinessOverviewandTotalRevenue(2020VS2018) 11.7.3Fresenius-kabiPaclitaxelSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021) 11.7.4Fresenius-kabiPaclitaxelProductsandServices 11.7.5Fresenius-kabiSWOTAnalysis 11.7.6Fresenius-kabiRecentDevelopments 11.8Huiangbiopharma 11.8.1HuiangbiopharmaCorporationInformation 11.8.2HuiangbiopharmaBusinessOverviewandTotalRevenue(2020VS2018) 11.8.3HuiangbiopharmaPaclitaxelSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021) 11.8.4HuiangbiopharmaPaclitaxelProductsandServices 11.8.5HuiangbiopharmaSWOTAnalysis 11.8.6HuiangbiopharmaRecentDevelopments 11.9Southpharma 11.9.1SouthpharmaCorporationInformation 11.9.2SouthpharmaBusinessOverviewandTotalRevenue(2020VS2018) 11.9.3SouthpharmaPaclitaxelSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021) 11.9.4SouthpharmaPaclitaxelProductsandServices 11.9.5SouthpharmaSWOTAnalysis 11.9.6SouthpharmaRecentDevelopments 11.10YunnanHande 11.10.1YunnanHandeCorporationInformation 11.10.2YunnanHandeBusinessOverviewandTotalRevenue(2020VS2018) 11.10.3YunnanHandePaclitaxelSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021) 11.10.4YunnanHandePaclitaxelProductsandServices 11.10.5YunnanHandeSWOTAnalysis 11.10.6YunnanHandeRecentDevelopments 11.11HainanYewPharm 11.11.1HainanYewPharmCorporationInformation 11.11.2HainanYewPharmBusinessOverviewandTotalRevenue(2020VS2018) 11.11.3HainanYewPharmPaclitaxelSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021) 11.11.4HainanYewPharmPaclitaxelProductsandServices 11.11.5HainanYewPharmSWOTAnalysis 11.11.6HainanYewPharmRecentDevelopments 11.12JiangsuYewBiotechnology 11.12.1JiangsuYewBiotechnologyCorporationInformation 11.12.2JiangsuYewBiotechnologyBusinessOverviewandTotalRevenue(2020VS2018) 11.12.3JiangsuYewBiotechnologyPaclitaxelSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021) 11.12.4JiangsuYewBiotechnologyPaclitaxelProductsandServices 11.12.5JiangsuYewBiotechnologySWOTAnalysis 11.12.6JiangsuYewBiotechnologyRecentDevelopments 12SupplyChainandSalesChannelsAnalysis 12.1SupplyChainAnalysis 12.2SalesChannelsAnalysis 12.2.1PaclitaxelSalesChannels 12.2.2PaclitaxelDistributors 12.3PaclitaxelCustomers 13EstimatesandProjectionsbyRegions(2021-2027) 13.1GlobalPaclitaxelSalesForecast(2021-2027) 13.1.1GlobalPaclitaxelSalesForecastbyRegions(2021-2027) 13.1.2GlobalPaclitaxelRevenueForecastbyRegions(2021-2027) 13.2NorthAmericaMarketSizeForecast(2021-2027) 13.2.1NorthAmericaPaclitaxelSalesForecast(2021-2027) 13.2.2NorthAmericaPaclitaxelRevenueForecast(2021-2027) 13.2.3NorthAmericaPaclitaxelSizeForecastbyCounty(2021-2027) 13.3EuropeMarketSizeForecast(2021-2027) 13.3.1EuropePaclitaxelSalesForecast(2021-2027) 13.3.2EuropePaclitaxelRevenueForecast(2021-2027) 13.3.3EuropePaclitaxelSizeForecastbyCounty(2021-2027) 13.4AsiaPacificMarketSizeForecast(2021-2027) 13.4.1AsiaPacificPaclitaxelSalesForecast(2021-2027) 13.4.2AsiaPacificPaclitaxelRevenueForecast(2021-2027) 13.4.3AsiaPacificPaclitaxelSizeForecastbyRegion(2021-2027) 13.5LatinAmericaMarketSizeForecast(2021-2027) 13.5.1LatinAmericaPaclitaxelSalesForecast(2021-2027) 13.5.2LatinAmericaPaclitaxelRevenueForecast(2021-2027) 13.5.3LatinAmericaPaclitaxelSizeForecastbyCounty(2021-2027) 13.6MiddleEastandAfricaMarketForecast 13.6.1MiddleEastandAfricaPaclitaxelSalesForecast(2021-2027) 13.6.2MiddleEastandAfricaPaclitaxelRevenueForecast(2021-2027) 13.6.3MiddleEastandAfricaPaclitaxelSizeForecastbyCounty(2021-2027) 14ResearchFindingsandConclusion 15Appendix 15.1ResearchMethodology 15.1.1Methodology/ResearchApproach 15.1.2DataSource 15.2AuthorDetails 15.3Disclaimer

List of Tables
Table 1. Paclitaxel Key Market Segments
Table 2. Ranking of Global Top Paclitaxel Manufacturers by Revenue (US$ Million) in 2020
Table 3. Global Paclitaxel Market Size Growth Rate by Type 2021-2027 (Kg) & (Million US$)
Table 4. Major Manufacturers of Natural Paclitaxel API
Table 5. Major Manufacturers of Semi-synthetic Paclitaxel API
Table 6. Global Paclitaxel Market Share by Application 2020-2025 (Kg)
Table 7. Global Paclitaxel Market Size by Regions 2016-2021 (Kg) & (Million US$)
Table 8. Global Paclitaxel Sales by Regions 2016-2021 (Kg)
Table 9. Global Paclitaxel Sales Market Share by Regions 2016-2021
Table 10. Global Paclitaxel Revenue by Regions 2016-2021 (Million US$)
Table 11. Global Paclitaxel Revenue Market Share by Regions 2016-2021
Table 12. Top Paclitaxel Regions (Countries) Ranking by Market Size (US$ Million) in 2020
Table 13. Market Top Trends
Table 14. Paclitaxel Key Drivers: Impact Analysis (2021-2027)
Table 15. Paclitaxel Key Challenges
Table 16. Main Points Interviewed from Key Paclitaxel Players: Views for Future
Table 17. Global Paclitaxel Sales by Manufacturers (2016-2021) (Kg)
Table 18. Global Paclitaxel Sales Share by Manufacturers (2016-2021)
Table 19. Paclitaxel Revenue by Manufacturers (2016-2021) (Million US$)
Table 20. Paclitaxel Revenue Share by Manufacturers (2016-2021)
Table 21. Global Paclitaxel Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Paclitaxel as of 2020)
Table 23. Key Manufacturers Paclitaxel Average Selling Price (ASP) (2016-2021) (USD/Kg)
Table 24. Key Manufacturers Paclitaxel Plants/Factories Distribution
Table 25. Key Manufacturers Paclitaxel Area Served
Table 26. Date of Key Manufacturers Enter into Paclitaxel Market
Table 27. Key Manufacturers Paclitaxel Product Type
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Natural Paclitaxel API Sales and Revenue (2016-2021) (Kg) & (Million US$)
Table 30. Global Semi-synthetic Paclitaxel API Sales and Revenue (2016-2021) (Kg) & (Million US$)
Table 31. Global Paclitaxel Sales (Kg) by Type (2016-2021)
Table 32. Global Paclitaxel Sales Share by Type (2016-2021)
Table 33. Global Paclitaxel Revenue (US$ Million) Market Share by Type (2016-2021)
Table 34. Global Paclitaxel Price (Kg) by Type (2016-2021)
Table 35. Global Paclitaxel Sales (Kg) by Type (2021-2027)
Table 36. Global Paclitaxel Sales Share by Type (2021-2027)
Table 37. Global Paclitaxel Revenue (US$ Million) Market Share by Type (2021-2027)
Table 38. Global Paclitaxel Revenue Share by Type (2021-2027)
Table 39. Global Paclitaxel Price (Kg) by Type (2021-2027)
Table 40. Global Paclitaxel Sales (Kg) by Application (2016-2021)
Table 41. Global Paclitaxel Sales Share by Application (2016-2021)
Table 42. Global Paclitaxel Revenue (US$ Million) Market Share by Application (2016-2021)
Table 43. Global Paclitaxel Price by Application 2016-2021 (USD/Kg)
Table 44. Global Paclitaxel Sales by Application (2016-2021) (Kg)
Table 45. Global Paclitaxel Sales Share by Application (2016-2021)
Table 46. Global Paclitaxel Revenue (US$ Million) Market Share by Application (2021-2027)
Table 47. Global Paclitaxel Revenue Share by Application (2021-2027)
Table 48. Global Paclitaxel Price (Kg) by Application (2021-2027)
Table 49. North America Paclitaxel Sales by Company (2016-2021) (Kg)
Table 50. North America Paclitaxel Sales Market Share by Company (2016-2021)
Table 51. North America Paclitaxel Sales by Type (2016-2021) (Kg)
Table 52. North America Paclitaxel Sales Market Share by Type (2016-2021)
Table 53. North America Paclitaxel Sales by Application (2016-2021) (Kg)
Table 54. North America Paclitaxel Sales Market Share by Application (2016-2021)
Table 55. North America Paclitaxel Sales by Countries (2016-2021) (Kg)
Table 56. North America Paclitaxel Sales Market Share by Countries (2016-2021)
Table 57. North America Paclitaxel Revenue by Countries (2016-2021) (Million US$)
Table 58. North America Paclitaxel Revenue Market Share by Countries (2016-2021)
Table 59. Europe Paclitaxel Sales by Company (2016-2021) (Kg)
Table 60. Europe Paclitaxel Sales Market Share by Company (2016-2021)
Table 61. Europe Paclitaxel Sales by Type (2016-2021) (Kg)
Table 62. Europe Paclitaxel Sales Market Share by Type (2016-2021)
Table 63. Europe Paclitaxel Sales by Application (2016-2021) (Kg)
Table 64. Europe Paclitaxel Sales Market Share by Application (2016-2021)
Table 65. Europe Paclitaxel Sales by Countries (2016-2021) (Kg)
Table 66. Europe Paclitaxel Sales Market Share by Countries (2016-2021)
Table 67. Europe Paclitaxel Revenue by Countries (2016-2021) (Million US$)
Table 68. Europe Paclitaxel Revenue Market Share by Countries (2016-2021)
Table 69. Asia Pacific Paclitaxel Sales by Regions (2016-2021) (Kg)
Table 70. Asia Pacific Paclitaxel Sales Market Share by Regions (2016-2021)
Table 71. Asia Pacific Paclitaxel Sales by Type (2016-2021) (Kg)
Table 72. Asia Pacific Paclitaxel Sales Market Share by Type (2016-2021)
Table 73. Asia Pacific Paclitaxel Sales by Application (2016-2021) (Kg)
Table 74. Asia Pacific Paclitaxel Sales Market Share by Application (2016-2021)
Table 75. Asia Pacific Paclitaxel Sales by Countries (2016-2021) (Kg)
Table 76. Asia Pacific Paclitaxel Sales Market Share by Regions (2016-2021)
Table 77. Asia Pacific Paclitaxel Revenue by Regions (2016-2021) (Million US$)
Table 78. Asia Pacific Paclitaxel Revenue Market Share by Regions (2016-2021)
Table 79. Latin America Paclitaxel Sales by Company (2016-2021) (Kg)
Table 80. Latin America Paclitaxel Sales Market Share by Company (2016-2021)
Table 81. Latin America Paclitaxel Sales by Type (2016-2021) (Kg)
Table 82. Latin America Paclitaxel Sales Market Share by Type (2016-2021)
Table 83. Latin America Paclitaxel Sales by Application (2016-2021) (Kg)
Table 84. Latin America Paclitaxel Sales Market Share by Application (2016-2021)
Table 85. Latin America Paclitaxel Sales by Countries (2016-2021) (Kg)
Table 86. Latin America Paclitaxel Sales Market Share by Countries (2016-2021)
Table 87. Latin America Paclitaxel Revenue by Countries (2016-2021) (Million US$)
Table 88. Latin America Paclitaxel Revenue Market Share by Countries (2016-2021)
Table 89. Middle East and Africa Paclitaxel Sales by Type (2016-2021) (Kg)
Table 90. Middle East and Africa Paclitaxel Sales Market Share by Type (2016-2021)
Table 91. Middle East and Africa Paclitaxel Sales by Application (2016-2021) (Kg)
Table 92. Middle East and Africa Paclitaxel Sales Market Share by Application (2016-2021)
Table 93. Middle East and Africa Paclitaxel Sales by Countries (2016-2021) (Kg)
Table 94. Middle East and Africa Paclitaxel Sales Market Share by Countries (2016-2021)
Table 95. Middle East and Africa Paclitaxel Revenue by Countries (2016-2021) (Million US$)
Table 96. Middle East and Africa Paclitaxel Revenue Market Share by Countries (2016-2021)
Table 97. Phyton Company Details
Table 98. Phyton Description and Business Overview
Table 99. Phyton Paclitaxel Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 100. Phyton Paclitaxel Sales Growth Rate (2016-2021)
Table 101. Phyton Paclitaxel Sales Market Share in Global Market
Table 102. Phyton Recent Development
Table 103. ScinoPharm Company Details
Table 104. ScinoPharm Description and Business Overview
Table 105. ScinoPharm Paclitaxel Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 106. ScinoPharm Paclitaxel Sales Growth Rate (2016-2021)
Table 107. ScinoPharm Paclitaxel Sales Market Share in Global Market
Table 108. ScinoPharm Recent Development
Table 109. Novasep Company Details
Table 110. Novasep Description and Business Overview
Table 111. Novasep Paclitaxel Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 112. Novasep Paclitaxel Sales Growth Rate (2016-2021)
Table 113. Novasep Paclitaxel Sales Market Share in Global Market
Table 114. Novasep Recent Development
Table 115. Samyang Company Details
Table 116. Samyang Description and Business Overview
Table 117. Samyang Paclitaxel Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 118. Samyang Paclitaxel Sales Growth Rate (2016-2021)
Table 119. Samyang Paclitaxel Sales Market Share in Global Market
Table 120. Samyang Recent Development
Table 121. Polymed Company Details
Table 122. Polymed Description and Business Overview
Table 123. Polymed Paclitaxel Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 124. Polymed Paclitaxel Sales Growth Rate (2016-2021)
Table 125. Polymed Paclitaxel Sales Market Share in Global Market
Table 126. Polymed Recent Development
Table 127. TAPI (Teva) Company Details
Table 128. TAPI (Teva) Description and Business Overview
Table 129. TAPI (Teva) Paclitaxel Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 130. TAPI (Teva) Paclitaxel Sales Growth Rate (2016-2021)
Table 131. TAPI (Teva) Paclitaxel Sales Market Share in Global Market
Table 132. TAPI (Teva) Recent Development
Table 133. Fresenius-kabi Company Details
Table 134. Fresenius-kabi Description and Business Overview
Table 135. Fresenius-kabi Paclitaxel Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 136. Fresenius-kabi Paclitaxel Sales Growth Rate (2016-2021)
Table 137. Fresenius-kabi Paclitaxel Sales Market Share in Global Market
Table 138. Fresenius-kabi Recent Development
Table 139. Huiang biopharma Company Details
Table 140. Huiang biopharma Description and Business Overview
Table 141. Huiang biopharma Paclitaxel Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 142. Huiang biopharma Paclitaxel Sales Growth Rate (2016-2021)
Table 143. Huiang biopharma Paclitaxel Sales Market Share in Global Market
Table 144. Huiang biopharma Recent Development
Table 145. Southpharma Company Details
Table 146. Southpharma Description and Business Overview
Table 147. Southpharma Paclitaxel Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 148. Southpharma Paclitaxel Sales Growth Rate (2016-2021)
Table 149. Southpharma Paclitaxel Sales Market Share in Global Market
Table 150. Southpharma Recent Development
Table 151. Yunnan Hande Company Details
Table 152. Yunnan Hande Description and Business Overview
Table 153. Yunnan Hande Paclitaxel Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 154. Yunnan Hande Paclitaxel Sales Growth Rate (2016-2021)
Table 155. Yunnan Hande Paclitaxel Sales Market Share in Global Market
Table 156. Yunnan Hande Recent Development
Table 157. Hainan Yew Pharm Company Details
Table 158. Hainan Yew Pharm Description and Business Overview
Table 159. Hainan Yew Pharm Paclitaxel Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 160. Hainan Yew Pharm Paclitaxel Sales Growth Rate (2016-2021)
Table 161. Hainan Yew Pharm Paclitaxel Sales Market Share in Global Market
Table 162. Hainan Yew Pharm Recent Development
Table 163. Jiangsu Yew Biotechnology Company Details
Table 164. Jiangsu Yew Biotechnology Description and Business Overview
Table 165. Jiangsu Yew Biotechnology Paclitaxel Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 166. Jiangsu Yew Biotechnology Paclitaxel Sales Growth Rate (2016-2021)
Table 167. Jiangsu Yew Biotechnology Paclitaxel Sales Market Share in Global Market
Table 168. Jiangsu Yew Biotechnology Recent Development
Table 169. Paclitaxel Distributors List
Table 170. Paclitaxel Customers List
Table 171. Global Paclitaxel Sales Forecast 2021-2027 (Kg) & (Million US$)
Table 172. Global Paclitaxel Sales Forecast by Type 2021-2027 (Kg)
Table 173. Global Paclitaxel Sales Forecast by Application 2021-2027 (Kg)
Table 174. Global Paclitaxel Sales Forecast by Regions 2021-2027 (Kg)
Table 175. Global Paclitaxel Revenue Forecast by Regions 2021-2027 (Million US$)
Table 176. North America Paclitaxel Sales Forecast by Countries 2021-2027 (Kg)
Table 177. North America Paclitaxel Revenue Forecast by Countries 2021-2027
Table 178. Europe Paclitaxel Sales Forecast by Countries 2021-2027 (Kg)
Table 179. Europe Paclitaxel Revenue Market Share Forecast by Countries 2021-2027
Table 180. Asia Pacific Paclitaxel Sales Forecast by Regions 2021-2027 (Kg)
Table 181. Asia Pacific Paclitaxel Revenue Forecast by Regions 2021-2027 (Million US$)
Table 182. Latin America Paclitaxel Sales Forecast by Countries 2021-2027 (Kg)
Table 183. Latin America Paclitaxel Revenue Forecast by Countries 2021-2027 (Million US$)
Table 184. Middle East and Africa Paclitaxel Sales Forecast by Regions 2021-2027 (Kg)
Table 185. Middle East and Africa Paclitaxel Revenue Forecast by Regions 2021-2027 (Million US$)
Table 186. Research Programs/Design for This Report
Table 187. Key Data Information from Secondary Sources
Table 188. Key Data Information from Primary Sources
List of Figures
Figure 1. Paclitaxel Product Picture
Figure 2. Global Paclitaxel Sales Market Shar by Type 2016-2027
Figure 3. Natural Paclitaxel API Figures
Figure 4. Semi-synthetic Paclitaxel API Figures
Figure 5. Global Paclitaxel Sales Market Share by Application in 2020 & 2027
Figure 6. Ovarian Cancer Use Case
Figure 7. Cervical Cancer Use Case
Figure 8. Breast Cancer Use Case
Figure 9. Other Use Case
Figure 10. Paclitaxel Report Years Considered
Figure 11. Global Paclitaxel Market Size 2016-2027 (Million US$)
Figure 12. Global Paclitaxel Sales 2016-2021 (Kg)
Figure 13. Global Paclitaxel Market Size Market Share by Regions 2016-2021
Figure 14. Global Paclitaxel Sales Market Share by Regions in 2020
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Paclitaxel Sales Share by Manufacturers in 2020
Figure 17. The 5 and 10 Largest Manufacturers in the World: Market Share by Paclitaxel Sales in 2020
Figure 18. Paclitaxel Value Share by Manufacturers in 2020
Figure 19. Paclitaxel Revenue Share by Manufacturers In 2020
Figure 20. Paclitaxel Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 21. Global Paclitaxel Revenue Share by Type (2016-2021)
Figure 22. Global Paclitaxel Revenue Growth Rate by Type in 2016 & 2020
Figure 23. Global Paclitaxel Market Share by Price Range (2016-2021)
Figure 24. Global Paclitaxel Revenue Share by Application (2016-2021)
Figure 25. Global Paclitaxel Revenue Growth Rate by Application in 2016 & 2020
Figure 26. North America Paclitaxel Revenue Growth Rate 2016-2021 (Million US$)
Figure 27. U.S. Paclitaxel Sales Growth Rate (2016-2021) (Kg)
Figure 28. Canada Paclitaxel Sales Growth Rate (2016-2021) (Kg)
Figure 29. Europe Paclitaxel Revenue Growth Rate 2016-2021 (Million US$)
Figure 30. Germany Paclitaxel Sales Growth Rate (2016-2021) (Kg)
Figure 31. France Paclitaxel Sales Growth Rate (2016-2021) (Kg)
Figure 32. U.K. Paclitaxel Sales Growth Rate (2016-2021) (Kg)
Figure 33. Italy Paclitaxel Sales Growth Rate (2016-2021) (Kg)
Figure 34. Russia Paclitaxel Sales Growth Rate (2016-2021) (Kg)
Figure 35. Asia Pacific Paclitaxel Revenue Growth Rate 2016-2021 (Million US$)
Figure 36. China Paclitaxel Sales Growth Rate (2016-2021) (Kg)
Figure 37. Japan Paclitaxel Sales Growth Rate (2016-2021) (Kg)
Figure 38. South Korea Paclitaxel Sales Growth Rate (2016-2021) (Kg)
Figure 39. India Paclitaxel Sales Growth Rate (2016-2021) (Kg)
Figure 40. Australia Paclitaxel Sales Growth Rate (2016-2021) (Kg)
Figure 41. Taiwan Paclitaxel Sales Growth Rate (2016-2021) (Kg)
Figure 42. Indonesia Paclitaxel Sales Growth Rate (2016-2021) (Kg)
Figure 43. Thailand Paclitaxel Sales Growth Rate (2016-2021) (Kg)
Figure 44. Malaysia Paclitaxel Sales Growth Rate (2016-2021) (Kg)
Figure 45. Philippines Paclitaxel Sales Growth Rate (2016-2021) (Kg)
Figure 46. Vietnam Paclitaxel Sales Growth Rate (2016-2021) (Kg)
Figure 47. Latin America Paclitaxel Revenue Growth Rate 2016-2021 (Million US$)
Figure 48. Mexico Paclitaxel Sales Growth Rate (2016-2021) (Kg)
Figure 49. Brazil Paclitaxel Sales Growth Rate (2016-2021) (Kg)
Figure 50. Argentina Paclitaxel Sales Growth Rate (2016-2021) (Kg)
Figure 51. Middle East and Africa Paclitaxel Revenue Growth Rate 2016-2021 (Million US$)
Figure 52. Turkey Paclitaxel Sales Growth Rate (2016-2021) (Kg)
Figure 53. Saudi Arabia Paclitaxel Sales Growth Rate (2016-2021) (Kg)
Figure 54. U.A.E Paclitaxel Sales Growth Rate (2016-2021) (Kg)
Figure 55. Phyton Total Revenue (US$ Million): 2020 Compared with 2018
Figure 56. ScinoPharm Total Revenue (US$ Million): 2020 Compared with 2018
Figure 57. Novasep Total Revenue (US$ Million): 2020 Compared with 2018
Figure 58. Samyang Total Revenue (US$ Million): 2020 Compared with 2018
Figure 59. Polymed Total Revenue (US$ Million): 2020 Compared with 2018
Figure 60. TAPI (Teva) Total Revenue (US$ Million): 2020 Compared with 2018
Figure 61. Fresenius-kabi Total Revenue (US$ Million): 2020 Compared with 2018
Figure 62. Huiang biopharma Total Revenue (US$ Million): 2020 Compared with 2018
Figure 63. Southpharma Total Revenue (US$ Million): 2020 Compared with 2018
Figure 64. Yunnan Hande Total Revenue (US$ Million): 2020 Compared with 2018
Figure 65. Hainan Yew Pharm Total Revenue (US$ Million): 2020 Compared with 2018
Figure 66. Jiangsu Yew Biotechnology Total Revenue (US$ Million): 2020 Compared with 2018
Figure 67. Paclitaxel Value Chain
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
Figure 70. North America Paclitaxel Sales Growth Rate Forecast (2021-2027) (Kg)
Figure 71. North America Paclitaxel Revenue Growth Rate Forecast (2021-2027) (US$ Million)
Figure 72. Europe Paclitaxel Sales Growth Rate Forecast (2021-2027) (Kg)
Figure 73. Europe Paclitaxel Revenue Growth Rate Forecast (2021-2027) (US$ Million)
Figure 74. Asia Pacific Paclitaxel Sales Growth Rate Forecast (2021-2027) (Kg)
Figure 75. Asia Pacific Paclitaxel Revenue Growth Rate Forecast (2021-2027) (US$ Million)
Figure 76. Latin America Paclitaxel Sales Growth Rate Forecast (2021-2027) (Kg)
Figure 77. Latin America Paclitaxel Revenue Growth Rate Forecast (2021-2027) (US$ Million)
Figure 78. Middle East and Africa Paclitaxel Sales Growth Rate Forecast (2021-2027) (Kg)
Figure 79. Middle East and Africa Paclitaxel Revenue Growth Rate Forecast (2021-2027) (US$ Million)
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed

Paclitaxel Market Segments


Paclitaxel Product Type Outlook (Revenue, USD Million, 2021 2027)


  • Natural Paclitaxel API
  • Semi-synthetic Paclitaxel API

Paclitaxel Application Outlook (Revenue, USD Million, 2021 2027)


  • Ovarian Cancer
  • Cervical Cancer
  • Breast Cancer
  • Other

Paclitaxel Regional Outlook (Revenue, USD Million, 2021 2027)


  • North America
    • Paclitaxel market, By Product Type Outlook
      • Natural Paclitaxel API
      • Semi-synthetic Paclitaxel API

    • Paclitaxel market, By Application Outlook
      • Ovarian Cancer
      • Cervical Cancer
      • Breast Cancer
      • Other

  • Europe
    • Paclitaxel market, By Product Type Outlook
      • Natural Paclitaxel API
      • Semi-synthetic Paclitaxel API

    • Paclitaxel market, By Application Outlook
      • Ovarian Cancer
      • Cervical Cancer
      • Breast Cancer
      • Other

  • Asia Pacific
    • Paclitaxel market, By Product Type Outlook
      • Natural Paclitaxel API
      • Semi-synthetic Paclitaxel API

    • Paclitaxel market, By Application Outlook
      • Ovarian Cancer
      • Cervical Cancer
      • Breast Cancer
      • Other

  • Latin America
    • Paclitaxel market, By Product Type Outlook
      • Natural Paclitaxel API
      • Semi-synthetic Paclitaxel API

    • Paclitaxel market, By Application Outlook
      • Ovarian Cancer
      • Cervical Cancer
      • Breast Cancer
      • Other

  • Middle East & Africa
    • Paclitaxel market, By Product Type Outlook
      • Natural Paclitaxel API
      • Semi-synthetic Paclitaxel API

    • Paclitaxel market, By Application Outlook
      • Ovarian Cancer
      • Cervical Cancer
      • Breast Cancer
      • Other

Report Content:


Qualitative Analysis


  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porters analysis
  • PESTEL Analysis
  • Value Chain Analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Overview
    • Financials
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis


  • Market size, estimates, and forecasts from 2021 - 2027
  • Market revenue estimates for product type up to 2027
  • Market revenue estimates for application type up to 2027
  • Regional market size and forecast up to 2027
  • Company financials

Report Description


The Global Paclitaxel Market Report provides Insightful information to the clients enhancing their basic leadership capacity identified with the global Paclitaxel Market business, including market dynamics, segmentation, competition, and regional growth. The strategy of expansion has been adopted by key players who are increasing their production capacities to cater to the increasing demand for various application.

New traders at intervals the Paclitaxel Market face strong competition from ancient world traders as they try with technological revolutions, dependableness and commonplace of Paclitaxel Market product affairs. The report is at risk of project regarding this Paclitaxel Market evolutions and additionally the magnitude of competition, value and extra.

Leading market players: (Option 1: Free 25% Customization Profiles of 5 Additional Companies of your Choice)


This business intelligence report offers profiling of reputed companies that are operating in the market. Companies such as:

  • Phyton
  • ScinoPharm
  • Novasep
  • Samyang
  • Polymed
  • TAPI (Teva)
  • Fresenius-kabi
  • Huiang biopharma
  • Southpharma
  • Yunnan Hande
  • Hainan Yew Pharm
  • Jiangsu Yew Biotechnology

Others players have been profiled into detail so as to offer a glimpse of the market leaders. Moreover, parameters such as Paclitaxel related investment & spending and developments by major players of the market are tracked in this Global report.

Years considered for the study:


Paclitaxel Market

Paclitaxel Market

Report Highlights:


The Paclitaxel Market is widely partitioned reliant on the predictable updates in the enhancement of parameters for example, quality, trustworthiness, end customer solicitations, applications, and others. The Paclitaxel Market report contains general successful parameters, confinements, and besides has in detail illumination of the noteworthy data close by the present and future examples that may concern the advancement. The comprehensive Paclitaxel Market report elucidates within and outside representation of current advancements, parameters, and establishments.

The key regions analyzed in this study include North America, Europe, Japan, China, India, Korea, South East Asia, South America, Middle East and African countries. The leading players of Paclitaxel Market and their geographical presence across the globe are estimated based on production capacity, utilization ratio, consumer base, demand and supply scenario, profit margin and Paclitaxel marketers.

Data Lab Forecast performed primary as well as exhaustive secondary research for this study. We conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, DLF was able to include manufacturers that could not be identified due to the limitations of secondary research. We analysed product offerings, distribution channel and regional presence of all major companies in the industry.

Data Lab Forecast calculated the market size for the Paclitaxel market using a bottom-up approach, wherein manufacturers value data for different type (Natural Paclitaxel API, Semi-synthetic Paclitaxel API), of Paclitaxel market was recorded as well as forecast for the future years was made. Data Lab Forecast sourced these values from industry experts and company representatives, and externally validated through analyzing historical sales data of respective manufacturers to arrive at the overall market size. Various secondary sources such as company annual reports, white papers, investor presentations and financial reports were also studied by Data Lab Forecast.

Paclitaxel Market

Paclitaxel Market

Key Target Audience:


  • Paclitaxel market companies.
  • Research organizations and consulting companies.
  • Organizations, associations and alliances related to the Paclitaxel market industry.
  • Government bodies such as regulating authorities and policymakers.
  • Industry associations.

The study is useful in providing answers to several critical questions that are important for industry stakeholders, such as manufacturers, distributors, dealers and policymakers, about which market segments should be targeted over retail cosmetics outlets in coming years to strategize investments and capitalize on growth of the market.

Report Scope:


In this report, Paclitaxel market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

In terms of type, the Global Paclitaxel market is segregated into:


The report includes in-detail references of all the notable product categories as well as application specifications. The product segment is described on the basis of key player development traits, sales overview, volume based returns and the like.

  • Natural Paclitaxel API
  • Semi-synthetic Paclitaxel API

By end-user also classify into, the Global Paclitaxel market:


Global Paclitaxel market also specifically underpins end-use application scope and their improvements based on technological developments and consumer preferences.

  • Ovarian Cancer
  • Cervical Cancer
  • Breast Cancer
  • Other

Highlights of this 2021-2027 Paclitaxel Market Report:

  • Market dynamics, Paclitaxel economy manufacturing, opportunities on the total pricing of this top manufacturer and improvement trend analysis;
  • Paclitaxel industry players at the general regional industry and economy synopsis;
  • Deep analysis of the most significant market players included by Worldwide Paclitaxel Market study report;
  • Understand more about the market plans that are increasingly now being adopted by leading Paclitaxel businesses;
  • Evaluation of this market character, namely market development drivers, essential challengers, inhibitors, and chances;
  • Strategically profile the key players and comprehensively analyze their growth strategies.

Competitive Landscape:

Company Profiles: Detailed analysis of the major companies presents in the Paclitaxel market.

Product Benchmarking: Benchmarking of most selling variant of all leading companies based on product type. In-depth analysis of benchmarking and recommendation on ideal product specifications.

Voice of Customer: Customer analysis by considering the major factors influencing the purchasing decision.

Available Customizations:

With the given market data, Data Lab Forecast offers customizations according to the companys specific needs. The following customization options are available for the report:

Channel Partner Analysis: Detailed list of distributors and dealers across the country.

Company Information: Detailed analysis and profiling of additional market players (up to five).

Product Information: Detailed analysis of new products in the market and their driving forces in the market.

In case you dont find what you are looking for, please get in touch with our custom research team at sales@datalabforecast.com
TableofContents 1ReportOverview 1.1ResearchScope 1.2TopPaclitaxelManufacturersCovered:RankingbyRevenue 1.3MarketSegmentbyType 1.3.1GlobalPaclitaxelMarketSizebyType:2016VS2021VS2027(US$Million) 1.3.2NaturalPaclitaxelAPI 1.3.3Semi-syntheticPaclitaxelAPI 1.4MarketSegmentbyApplication 1.4.1GlobalPaclitaxelConsumptionbyApplication:2016VS2021VS2027 1.4.2OvarianCancer 1.4.3CervicalCancer 1.4.4BreastCancer 1.4.5Other 1.5StudyObjectives 1.6YearsConsidered 2GlobalMarketPerspective 2.1GlobalPaclitaxelRevenue(2016-2027) 2.1.1GlobalPaclitaxelRevenue(2016-2027) 2.1.2GlobalPaclitaxelSales(2016-2027) 2.2PaclitaxelMarketSizeacrossKeyGeographiesWorldwide:2016VS2021VS2027 2.2.1GlobalPaclitaxelSalesbyRegions(2016-2021) 2.2.2GlobalPaclitaxelRevenuebyRegions(2016-2021) 2.3GlobalTopPaclitaxelRegions(Countries)RankingbyMarketSize 2.4PaclitaxelIndustryTrends 2.4.1PaclitaxelMarketTopTrends 2.4.2MarketDrivers 2.4.3PaclitaxelMarketChallenges 2.4.4PortersFiveForcesAnalysis 2.4.5PrimaryInterviewswithKeyPaclitaxelPlayers:ViewsforFuture 3CompetitiveLandscapebyManufacturers 3.1GlobalTopPaclitaxelManufacturersbySales(2016-2021) 3.1.1GlobalPaclitaxelSalesbyManufacturers(2016-2021) 3.1.2GlobalPaclitaxelSalesMarketSharebyManufacturers(2016-2021) 3.1.3Global5and10LargestManufacturersbyPaclitaxelSalesin2020 3.2GlobalTopManufacturersPaclitaxelbyRevenue 3.2.1GlobalPaclitaxelRevenuebyManufacturers(2016-2021) 3.2.2GlobalPaclitaxelRevenueSharebyManufacturers(2016-2021) 3.2.3GlobalPaclitaxelMarketConcentrationRatio(CR5andHHI) 3.3GlobalTopManufacturersbyCompanyType(Tier1,Tier2andTier3)(basedontheRevenueinPaclitaxelasof2020) 3.4GlobalPaclitaxelAverageSellingPrice(ASP)byManufacturers 3.5KeyManufacturersPaclitaxelPlants/FactoriesDistributionandAreaServed 3.6DateofKeyManufacturersEnterintoPaclitaxelMarket 3.7KeyManufacturersPaclitaxelProductOffered 3.8Mergers&Acquisitions,ExpansionPlans 4MarketSizebyType 4.1GlobalPaclitaxelHistoricMarketReviewbyType(2016-2021) 4.1.2GlobalPaclitaxelSalesMarketSharebyType(2016-2021) 4.1.3GlobalPaclitaxelRevenueMarketSharebyType(2016-2021) 4.1.4PaclitaxelPricebyType(2016-2021) 4.1GlobalPaclitaxelMarketEstimatesandForecastsbyType(2021-2027) 4.2.2GlobalPaclitaxelSalesForecastbyType(2021-2027) 4.2.3GlobalPaclitaxelRevenueForecastbyType(2021-2027) 4.2.4PaclitaxelPriceForecastbyType(2021-2027) 5GlobalPaclitaxelMarketSizebyApplication 5.1GlobalPaclitaxelHistoricMarketReviewbyApplication(2016-2021) 5.1.2GlobalPaclitaxelSalesMarketSharebyApplication(2016-2021) 5.1.3GlobalPaclitaxelRevenueMarketSharebyApplication(2016-2021) 5.1.4PaclitaxelPricebyApplication(2016-2021) 5.2GlobalPaclitaxelMarketEstimatesandForecastsbyApplication(2021-2027) 5.2.2GlobalPaclitaxelSalesForecastbyApplication(2021-2027) 5.2.3GlobalPaclitaxelRevenueForecastbyApplication(2021-2027) 5.2.4PaclitaxelPriceForecastbyApplication(2021-2027) 6NorthAmerica 6.1NorthAmericaPaclitaxelBreakdownDatabyCompany 6.2NorthAmericaPaclitaxelBreakdownDatabyType 6.3NorthAmericaPaclitaxelBreakdownDatabyApplication 6.4NorthAmericaPaclitaxelBreakdownDatabyCountries 6.4.1NorthAmericaPaclitaxelSalesbyCountries 6.4.2NorthAmericaPaclitaxelRevenuebyCountries 6.4.3U.S. 6.4.4Canada 7Europe 7.1EuropePaclitaxelBreakdownDatabyCompany 7.2EuropePaclitaxelBreakdownDatabyType 7.3EuropePaclitaxelBreakdownDatabyApplication 7.4EuropePaclitaxelBreakdownDatabyCountries 7.4.1EuropePaclitaxelSalesbyCountries 7.4.2EuropePaclitaxelRevenuebyCountries 7.4.3Germany 7.4.4France 7.4.5U.K. 7.4.6Italy 7.4.7Russia 8AsiaPacific 8.1AsiaPacificPaclitaxelBreakdownDatabyCompany 8.2AsiaPacificPaclitaxelBreakdownDatabyType 8.3AsiaPacificPaclitaxelBreakdownDatabyApplication 8.4AsiaPacificPaclitaxelBreakdownDatabyRegions 8.4.1AsiaPacificPaclitaxelSalesbyRegions 8.4.2AsiaPacificPaclitaxelRevenuebyRegions 8.4.3China 8.4.4Japan 8.4.5SouthKorea 8.4.6India 8.4.7Australia 8.4.8Taiwan 8.4.9Indonesia 8.4.10Thailand 8.4.11Malaysia 8.4.12Philippines 8.4.13Vietnam 9LatinAmerica 9.1LatinAmericaPaclitaxelBreakdownDatabyCompany 9.2LatinAmericaPaclitaxelBreakdownDatabyType 9.3LatinAmericaPaclitaxelBreakdownDatabyApplication 9.4LatinAmericaPaclitaxelBreakdownDatabyCountries 9.4.1LatinAmericaPaclitaxelSalesbyCountries 9.4.2LatinAmericaPaclitaxelRevenuebyCountries 9.4.3Mexico 9.4.4Brazil 9.4.5Argentina 10MiddleEastandAfrica 10.1MiddleEastandAfricaPaclitaxelBreakdownDatabyType 10.2MiddleEastandAfricaPaclitaxelBreakdownDatabyApplication 10.3MiddleEastandAfricaPaclitaxelBreakdownDatabyCountries 10.3.1MiddleEastandAfricaPaclitaxelSalesbyCountries 10.3.2MiddleEastandAfricaPaclitaxelRevenuebyCountries 10.3.3Turkey 10.3.4SaudiArabia 10.3.5U.A.E 11CompanyProfiles 11.1Phyton 11.1.1PhytonCorporationInformation 11.1.2PhytonBusinessOverviewandTotalRevenue(2020VS2018) 11.1.3PhytonPaclitaxelSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021) 11.1.4PhytonPaclitaxelProductsandServices 11.1.5PhytonSWOTAnalysis 11.1.6PhytonRecentDevelopments 11.2ScinoPharm 11.2.1ScinoPharmCorporationInformation 11.2.2ScinoPharmBusinessOverviewandTotalRevenue(2020VS2018) 11.2.3ScinoPharmPaclitaxelSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021) 11.2.4ScinoPharmPaclitaxelProductsandServices 11.2.5ScinoPharmSWOTAnalysis 11.2.6ScinoPharmRecentDevelopments 11.3Novasep 11.3.1NovasepCorporationInformation 11.3.2NovasepBusinessOverviewandTotalRevenue(2020VS2018) 11.3.3NovasepPaclitaxelSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021) 11.3.4NovasepPaclitaxelProductsandServices 11.3.5NovasepSWOTAnalysis 11.3.6NovasepRecentDevelopments 11.4Samyang 11.4.1SamyangCorporationInformation 11.4.2SamyangBusinessOverviewandTotalRevenue(2020VS2018) 11.4.3SamyangPaclitaxelSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021) 11.4.4SamyangPaclitaxelProductsandServices 11.4.5SamyangSWOTAnalysis 11.4.6SamyangRecentDevelopments 11.5Polymed 11.5.1PolymedCorporationInformation 11.5.2PolymedBusinessOverviewandTotalRevenue(2020VS2018) 11.5.3PolymedPaclitaxelSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021) 11.5.4PolymedPaclitaxelProductsandServices 11.5.5PolymedSWOTAnalysis 11.5.6PolymedRecentDevelopments 11.6TAPI(Teva) 11.6.1TAPI(Teva)CorporationInformation 11.6.2TAPI(Teva)BusinessOverviewandTotalRevenue(2020VS2018) 11.6.3TAPI(Teva)PaclitaxelSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021) 11.6.4TAPI(Teva)PaclitaxelProductsandServices 11.6.5TAPI(Teva)SWOTAnalysis 11.6.6TAPI(Teva)RecentDevelopments 11.7Fresenius-kabi 11.7.1Fresenius-kabiCorporationInformation 11.7.2Fresenius-kabiBusinessOverviewandTotalRevenue(2020VS2018) 11.7.3Fresenius-kabiPaclitaxelSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021) 11.7.4Fresenius-kabiPaclitaxelProductsandServices 11.7.5Fresenius-kabiSWOTAnalysis 11.7.6Fresenius-kabiRecentDevelopments 11.8Huiangbiopharma 11.8.1HuiangbiopharmaCorporationInformation 11.8.2HuiangbiopharmaBusinessOverviewandTotalRevenue(2020VS2018) 11.8.3HuiangbiopharmaPaclitaxelSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021) 11.8.4HuiangbiopharmaPaclitaxelProductsandServices 11.8.5HuiangbiopharmaSWOTAnalysis 11.8.6HuiangbiopharmaRecentDevelopments 11.9Southpharma 11.9.1SouthpharmaCorporationInformation 11.9.2SouthpharmaBusinessOverviewandTotalRevenue(2020VS2018) 11.9.3SouthpharmaPaclitaxelSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021) 11.9.4SouthpharmaPaclitaxelProductsandServices 11.9.5SouthpharmaSWOTAnalysis 11.9.6SouthpharmaRecentDevelopments 11.10YunnanHande 11.10.1YunnanHandeCorporationInformation 11.10.2YunnanHandeBusinessOverviewandTotalRevenue(2020VS2018) 11.10.3YunnanHandePaclitaxelSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021) 11.10.4YunnanHandePaclitaxelProductsandServices 11.10.5YunnanHandeSWOTAnalysis 11.10.6YunnanHandeRecentDevelopments 11.11HainanYewPharm 11.11.1HainanYewPharmCorporationInformation 11.11.2HainanYewPharmBusinessOverviewandTotalRevenue(2020VS2018) 11.11.3HainanYewPharmPaclitaxelSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021) 11.11.4HainanYewPharmPaclitaxelProductsandServices 11.11.5HainanYewPharmSWOTAnalysis 11.11.6HainanYewPharmRecentDevelopments 11.12JiangsuYewBiotechnology 11.12.1JiangsuYewBiotechnologyCorporationInformation 11.12.2JiangsuYewBiotechnologyBusinessOverviewandTotalRevenue(2020VS2018) 11.12.3JiangsuYewBiotechnologyPaclitaxelSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021) 11.12.4JiangsuYewBiotechnologyPaclitaxelProductsandServices 11.12.5JiangsuYewBiotechnologySWOTAnalysis 11.12.6JiangsuYewBiotechnologyRecentDevelopments 12SupplyChainandSalesChannelsAnalysis 12.1SupplyChainAnalysis 12.2SalesChannelsAnalysis 12.2.1PaclitaxelSalesChannels 12.2.2PaclitaxelDistributors 12.3PaclitaxelCustomers 13EstimatesandProjectionsbyRegions(2021-2027) 13.1GlobalPaclitaxelSalesForecast(2021-2027) 13.1.1GlobalPaclitaxelSalesForecastbyRegions(2021-2027) 13.1.2GlobalPaclitaxelRevenueForecastbyRegions(2021-2027) 13.2NorthAmericaMarketSizeForecast(2021-2027) 13.2.1NorthAmericaPaclitaxelSalesForecast(2021-2027) 13.2.2NorthAmericaPaclitaxelRevenueForecast(2021-2027) 13.2.3NorthAmericaPaclitaxelSizeForecastbyCounty(2021-2027) 13.3EuropeMarketSizeForecast(2021-2027) 13.3.1EuropePaclitaxelSalesForecast(2021-2027) 13.3.2EuropePaclitaxelRevenueForecast(2021-2027) 13.3.3EuropePaclitaxelSizeForecastbyCounty(2021-2027) 13.4AsiaPacificMarketSizeForecast(2021-2027) 13.4.1AsiaPacificPaclitaxelSalesForecast(2021-2027) 13.4.2AsiaPacificPaclitaxelRevenueForecast(2021-2027) 13.4.3AsiaPacificPaclitaxelSizeForecastbyRegion(2021-2027) 13.5LatinAmericaMarketSizeForecast(2021-2027) 13.5.1LatinAmericaPaclitaxelSalesForecast(2021-2027) 13.5.2LatinAmericaPaclitaxelRevenueForecast(2021-2027) 13.5.3LatinAmericaPaclitaxelSizeForecastbyCounty(2021-2027) 13.6MiddleEastandAfricaMarketForecast 13.6.1MiddleEastandAfricaPaclitaxelSalesForecast(2021-2027) 13.6.2MiddleEastandAfricaPaclitaxelRevenueForecast(2021-2027) 13.6.3MiddleEastandAfricaPaclitaxelSizeForecastbyCounty(2021-2027) 14ResearchFindingsandConclusion 15Appendix 15.1ResearchMethodology 15.1.1Methodology/ResearchApproach 15.1.2DataSource 15.2AuthorDetails 15.3Disclaimer

Paclitaxel Market Segments


Paclitaxel Product Type Outlook (Revenue, USD Million, 2021 2027)


  • Natural Paclitaxel API
  • Semi-synthetic Paclitaxel API

Paclitaxel Application Outlook (Revenue, USD Million, 2021 2027)


  • Ovarian Cancer
  • Cervical Cancer
  • Breast Cancer
  • Other

Paclitaxel Regional Outlook (Revenue, USD Million, 2021 2027)


  • North America
    • Paclitaxel market, By Product Type Outlook
      • Natural Paclitaxel API
      • Semi-synthetic Paclitaxel API

    • Paclitaxel market, By Application Outlook
      • Ovarian Cancer
      • Cervical Cancer
      • Breast Cancer
      • Other

  • Europe
    • Paclitaxel market, By Product Type Outlook
      • Natural Paclitaxel API
      • Semi-synthetic Paclitaxel API

    • Paclitaxel market, By Application Outlook
      • Ovarian Cancer
      • Cervical Cancer
      • Breast Cancer
      • Other

  • Asia Pacific
    • Paclitaxel market, By Product Type Outlook
      • Natural Paclitaxel API
      • Semi-synthetic Paclitaxel API

    • Paclitaxel market, By Application Outlook
      • Ovarian Cancer
      • Cervical Cancer
      • Breast Cancer
      • Other

  • Latin America
    • Paclitaxel market, By Product Type Outlook
      • Natural Paclitaxel API
      • Semi-synthetic Paclitaxel API

    • Paclitaxel market, By Application Outlook
      • Ovarian Cancer
      • Cervical Cancer
      • Breast Cancer
      • Other

  • Middle East & Africa
    • Paclitaxel market, By Product Type Outlook
      • Natural Paclitaxel API
      • Semi-synthetic Paclitaxel API

    • Paclitaxel market, By Application Outlook
      • Ovarian Cancer
      • Cervical Cancer
      • Breast Cancer
      • Other

Report Content:


Qualitative Analysis


  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porters analysis
  • PESTEL Analysis
  • Value Chain Analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Overview
    • Financials
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis


  • Market size, estimates, and forecasts from 2021 - 2027
  • Market revenue estimates for product type up to 2027
  • Market revenue estimates for application type up to 2027
  • Regional market size and forecast up to 2027
  • Company financials
List of Tables
Table 1. Paclitaxel Key Market Segments
Table 2. Ranking of Global Top Paclitaxel Manufacturers by Revenue (US$ Million) in 2020
Table 3. Global Paclitaxel Market Size Growth Rate by Type 2021-2027 (Kg) & (Million US$)
Table 4. Major Manufacturers of Natural Paclitaxel API
Table 5. Major Manufacturers of Semi-synthetic Paclitaxel API
Table 6. Global Paclitaxel Market Share by Application 2020-2025 (Kg)
Table 7. Global Paclitaxel Market Size by Regions 2016-2021 (Kg) & (Million US$)
Table 8. Global Paclitaxel Sales by Regions 2016-2021 (Kg)
Table 9. Global Paclitaxel Sales Market Share by Regions 2016-2021
Table 10. Global Paclitaxel Revenue by Regions 2016-2021 (Million US$)
Table 11. Global Paclitaxel Revenue Market Share by Regions 2016-2021
Table 12. Top Paclitaxel Regions (Countries) Ranking by Market Size (US$ Million) in 2020
Table 13. Market Top Trends
Table 14. Paclitaxel Key Drivers: Impact Analysis (2021-2027)
Table 15. Paclitaxel Key Challenges
Table 16. Main Points Interviewed from Key Paclitaxel Players: Views for Future
Table 17. Global Paclitaxel Sales by Manufacturers (2016-2021) (Kg)
Table 18. Global Paclitaxel Sales Share by Manufacturers (2016-2021)
Table 19. Paclitaxel Revenue by Manufacturers (2016-2021) (Million US$)
Table 20. Paclitaxel Revenue Share by Manufacturers (2016-2021)
Table 21. Global Paclitaxel Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Paclitaxel as of 2020)
Table 23. Key Manufacturers Paclitaxel Average Selling Price (ASP) (2016-2021) (USD/Kg)
Table 24. Key Manufacturers Paclitaxel Plants/Factories Distribution
Table 25. Key Manufacturers Paclitaxel Area Served
Table 26. Date of Key Manufacturers Enter into Paclitaxel Market
Table 27. Key Manufacturers Paclitaxel Product Type
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Natural Paclitaxel API Sales and Revenue (2016-2021) (Kg) & (Million US$)
Table 30. Global Semi-synthetic Paclitaxel API Sales and Revenue (2016-2021) (Kg) & (Million US$)
Table 31. Global Paclitaxel Sales (Kg) by Type (2016-2021)
Table 32. Global Paclitaxel Sales Share by Type (2016-2021)
Table 33. Global Paclitaxel Revenue (US$ Million) Market Share by Type (2016-2021)
Table 34. Global Paclitaxel Price (Kg) by Type (2016-2021)
Table 35. Global Paclitaxel Sales (Kg) by Type (2021-2027)
Table 36. Global Paclitaxel Sales Share by Type (2021-2027)
Table 37. Global Paclitaxel Revenue (US$ Million) Market Share by Type (2021-2027)
Table 38. Global Paclitaxel Revenue Share by Type (2021-2027)
Table 39. Global Paclitaxel Price (Kg) by Type (2021-2027)
Table 40. Global Paclitaxel Sales (Kg) by Application (2016-2021)
Table 41. Global Paclitaxel Sales Share by Application (2016-2021)
Table 42. Global Paclitaxel Revenue (US$ Million) Market Share by Application (2016-2021)
Table 43. Global Paclitaxel Price by Application 2016-2021 (USD/Kg)
Table 44. Global Paclitaxel Sales by Application (2016-2021) (Kg)
Table 45. Global Paclitaxel Sales Share by Application (2016-2021)
Table 46. Global Paclitaxel Revenue (US$ Million) Market Share by Application (2021-2027)
Table 47. Global Paclitaxel Revenue Share by Application (2021-2027)
Table 48. Global Paclitaxel Price (Kg) by Application (2021-2027)
Table 49. North America Paclitaxel Sales by Company (2016-2021) (Kg)
Table 50. North America Paclitaxel Sales Market Share by Company (2016-2021)
Table 51. North America Paclitaxel Sales by Type (2016-2021) (Kg)
Table 52. North America Paclitaxel Sales Market Share by Type (2016-2021)
Table 53. North America Paclitaxel Sales by Application (2016-2021) (Kg)
Table 54. North America Paclitaxel Sales Market Share by Application (2016-2021)
Table 55. North America Paclitaxel Sales by Countries (2016-2021) (Kg)
Table 56. North America Paclitaxel Sales Market Share by Countries (2016-2021)
Table 57. North America Paclitaxel Revenue by Countries (2016-2021) (Million US$)
Table 58. North America Paclitaxel Revenue Market Share by Countries (2016-2021)
Table 59. Europe Paclitaxel Sales by Company (2016-2021) (Kg)
Table 60. Europe Paclitaxel Sales Market Share by Company (2016-2021)
Table 61. Europe Paclitaxel Sales by Type (2016-2021) (Kg)
Table 62. Europe Paclitaxel Sales Market Share by Type (2016-2021)
Table 63. Europe Paclitaxel Sales by Application (2016-2021) (Kg)
Table 64. Europe Paclitaxel Sales Market Share by Application (2016-2021)
Table 65. Europe Paclitaxel Sales by Countries (2016-2021) (Kg)
Table 66. Europe Paclitaxel Sales Market Share by Countries (2016-2021)
Table 67. Europe Paclitaxel Revenue by Countries (2016-2021) (Million US$)
Table 68. Europe Paclitaxel Revenue Market Share by Countries (2016-2021)
Table 69. Asia Pacific Paclitaxel Sales by Regions (2016-2021) (Kg)
Table 70. Asia Pacific Paclitaxel Sales Market Share by Regions (2016-2021)
Table 71. Asia Pacific Paclitaxel Sales by Type (2016-2021) (Kg)
Table 72. Asia Pacific Paclitaxel Sales Market Share by Type (2016-2021)
Table 73. Asia Pacific Paclitaxel Sales by Application (2016-2021) (Kg)
Table 74. Asia Pacific Paclitaxel Sales Market Share by Application (2016-2021)
Table 75. Asia Pacific Paclitaxel Sales by Countries (2016-2021) (Kg)
Table 76. Asia Pacific Paclitaxel Sales Market Share by Regions (2016-2021)
Table 77. Asia Pacific Paclitaxel Revenue by Regions (2016-2021) (Million US$)
Table 78. Asia Pacific Paclitaxel Revenue Market Share by Regions (2016-2021)
Table 79. Latin America Paclitaxel Sales by Company (2016-2021) (Kg)
Table 80. Latin America Paclitaxel Sales Market Share by Company (2016-2021)
Table 81. Latin America Paclitaxel Sales by Type (2016-2021) (Kg)
Table 82. Latin America Paclitaxel Sales Market Share by Type (2016-2021)
Table 83. Latin America Paclitaxel Sales by Application (2016-2021) (Kg)
Table 84. Latin America Paclitaxel Sales Market Share by Application (2016-2021)
Table 85. Latin America Paclitaxel Sales by Countries (2016-2021) (Kg)
Table 86. Latin America Paclitaxel Sales Market Share by Countries (2016-2021)
Table 87. Latin America Paclitaxel Revenue by Countries (2016-2021) (Million US$)
Table 88. Latin America Paclitaxel Revenue Market Share by Countries (2016-2021)
Table 89. Middle East and Africa Paclitaxel Sales by Type (2016-2021) (Kg)
Table 90. Middle East and Africa Paclitaxel Sales Market Share by Type (2016-2021)
Table 91. Middle East and Africa Paclitaxel Sales by Application (2016-2021) (Kg)
Table 92. Middle East and Africa Paclitaxel Sales Market Share by Application (2016-2021)
Table 93. Middle East and Africa Paclitaxel Sales by Countries (2016-2021) (Kg)
Table 94. Middle East and Africa Paclitaxel Sales Market Share by Countries (2016-2021)
Table 95. Middle East and Africa Paclitaxel Revenue by Countries (2016-2021) (Million US$)
Table 96. Middle East and Africa Paclitaxel Revenue Market Share by Countries (2016-2021)
Table 97. Phyton Company Details
Table 98. Phyton Description and Business Overview
Table 99. Phyton Paclitaxel Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 100. Phyton Paclitaxel Sales Growth Rate (2016-2021)
Table 101. Phyton Paclitaxel Sales Market Share in Global Market
Table 102. Phyton Recent Development
Table 103. ScinoPharm Company Details
Table 104. ScinoPharm Description and Business Overview
Table 105. ScinoPharm Paclitaxel Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 106. ScinoPharm Paclitaxel Sales Growth Rate (2016-2021)
Table 107. ScinoPharm Paclitaxel Sales Market Share in Global Market
Table 108. ScinoPharm Recent Development
Table 109. Novasep Company Details
Table 110. Novasep Description and Business Overview
Table 111. Novasep Paclitaxel Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 112. Novasep Paclitaxel Sales Growth Rate (2016-2021)
Table 113. Novasep Paclitaxel Sales Market Share in Global Market
Table 114. Novasep Recent Development
Table 115. Samyang Company Details
Table 116. Samyang Description and Business Overview
Table 117. Samyang Paclitaxel Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 118. Samyang Paclitaxel Sales Growth Rate (2016-2021)
Table 119. Samyang Paclitaxel Sales Market Share in Global Market
Table 120. Samyang Recent Development
Table 121. Polymed Company Details
Table 122. Polymed Description and Business Overview
Table 123. Polymed Paclitaxel Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 124. Polymed Paclitaxel Sales Growth Rate (2016-2021)
Table 125. Polymed Paclitaxel Sales Market Share in Global Market
Table 126. Polymed Recent Development
Table 127. TAPI (Teva) Company Details
Table 128. TAPI (Teva) Description and Business Overview
Table 129. TAPI (Teva) Paclitaxel Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 130. TAPI (Teva) Paclitaxel Sales Growth Rate (2016-2021)
Table 131. TAPI (Teva) Paclitaxel Sales Market Share in Global Market
Table 132. TAPI (Teva) Recent Development
Table 133. Fresenius-kabi Company Details
Table 134. Fresenius-kabi Description and Business Overview
Table 135. Fresenius-kabi Paclitaxel Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 136. Fresenius-kabi Paclitaxel Sales Growth Rate (2016-2021)
Table 137. Fresenius-kabi Paclitaxel Sales Market Share in Global Market
Table 138. Fresenius-kabi Recent Development
Table 139. Huiang biopharma Company Details
Table 140. Huiang biopharma Description and Business Overview
Table 141. Huiang biopharma Paclitaxel Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 142. Huiang biopharma Paclitaxel Sales Growth Rate (2016-2021)
Table 143. Huiang biopharma Paclitaxel Sales Market Share in Global Market
Table 144. Huiang biopharma Recent Development
Table 145. Southpharma Company Details
Table 146. Southpharma Description and Business Overview
Table 147. Southpharma Paclitaxel Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 148. Southpharma Paclitaxel Sales Growth Rate (2016-2021)
Table 149. Southpharma Paclitaxel Sales Market Share in Global Market
Table 150. Southpharma Recent Development
Table 151. Yunnan Hande Company Details
Table 152. Yunnan Hande Description and Business Overview
Table 153. Yunnan Hande Paclitaxel Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 154. Yunnan Hande Paclitaxel Sales Growth Rate (2016-2021)
Table 155. Yunnan Hande Paclitaxel Sales Market Share in Global Market
Table 156. Yunnan Hande Recent Development
Table 157. Hainan Yew Pharm Company Details
Table 158. Hainan Yew Pharm Description and Business Overview
Table 159. Hainan Yew Pharm Paclitaxel Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 160. Hainan Yew Pharm Paclitaxel Sales Growth Rate (2016-2021)
Table 161. Hainan Yew Pharm Paclitaxel Sales Market Share in Global Market
Table 162. Hainan Yew Pharm Recent Development
Table 163. Jiangsu Yew Biotechnology Company Details
Table 164. Jiangsu Yew Biotechnology Description and Business Overview
Table 165. Jiangsu Yew Biotechnology Paclitaxel Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 166. Jiangsu Yew Biotechnology Paclitaxel Sales Growth Rate (2016-2021)
Table 167. Jiangsu Yew Biotechnology Paclitaxel Sales Market Share in Global Market
Table 168. Jiangsu Yew Biotechnology Recent Development
Table 169. Paclitaxel Distributors List
Table 170. Paclitaxel Customers List
Table 171. Global Paclitaxel Sales Forecast 2021-2027 (Kg) & (Million US$)
Table 172. Global Paclitaxel Sales Forecast by Type 2021-2027 (Kg)
Table 173. Global Paclitaxel Sales Forecast by Application 2021-2027 (Kg)
Table 174. Global Paclitaxel Sales Forecast by Regions 2021-2027 (Kg)
Table 175. Global Paclitaxel Revenue Forecast by Regions 2021-2027 (Million US$)
Table 176. North America Paclitaxel Sales Forecast by Countries 2021-2027 (Kg)
Table 177. North America Paclitaxel Revenue Forecast by Countries 2021-2027
Table 178. Europe Paclitaxel Sales Forecast by Countries 2021-2027 (Kg)
Table 179. Europe Paclitaxel Revenue Market Share Forecast by Countries 2021-2027
Table 180. Asia Pacific Paclitaxel Sales Forecast by Regions 2021-2027 (Kg)
Table 181. Asia Pacific Paclitaxel Revenue Forecast by Regions 2021-2027 (Million US$)
Table 182. Latin America Paclitaxel Sales Forecast by Countries 2021-2027 (Kg)
Table 183. Latin America Paclitaxel Revenue Forecast by Countries 2021-2027 (Million US$)
Table 184. Middle East and Africa Paclitaxel Sales Forecast by Regions 2021-2027 (Kg)
Table 185. Middle East and Africa Paclitaxel Revenue Forecast by Regions 2021-2027 (Million US$)
Table 186. Research Programs/Design for This Report
Table 187. Key Data Information from Secondary Sources
Table 188. Key Data Information from Primary Sources
List of Figures
Figure 1. Paclitaxel Product Picture
Figure 2. Global Paclitaxel Sales Market Shar by Type 2016-2027
Figure 3. Natural Paclitaxel API Figures
Figure 4. Semi-synthetic Paclitaxel API Figures
Figure 5. Global Paclitaxel Sales Market Share by Application in 2020 & 2027
Figure 6. Ovarian Cancer Use Case
Figure 7. Cervical Cancer Use Case
Figure 8. Breast Cancer Use Case
Figure 9. Other Use Case
Figure 10. Paclitaxel Report Years Considered
Figure 11. Global Paclitaxel Market Size 2016-2027 (Million US$)
Figure 12. Global Paclitaxel Sales 2016-2021 (Kg)
Figure 13. Global Paclitaxel Market Size Market Share by Regions 2016-2021
Figure 14. Global Paclitaxel Sales Market Share by Regions in 2020
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Paclitaxel Sales Share by Manufacturers in 2020
Figure 17. The 5 and 10 Largest Manufacturers in the World: Market Share by Paclitaxel Sales in 2020
Figure 18. Paclitaxel Value Share by Manufacturers in 2020
Figure 19. Paclitaxel Revenue Share by Manufacturers In 2020
Figure 20. Paclitaxel Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 21. Global Paclitaxel Revenue Share by Type (2016-2021)
Figure 22. Global Paclitaxel Revenue Growth Rate by Type in 2016 & 2020
Figure 23. Global Paclitaxel Market Share by Price Range (2016-2021)
Figure 24. Global Paclitaxel Revenue Share by Application (2016-2021)
Figure 25. Global Paclitaxel Revenue Growth Rate by Application in 2016 & 2020
Figure 26. North America Paclitaxel Revenue Growth Rate 2016-2021 (Million US$)
Figure 27. U.S. Paclitaxel Sales Growth Rate (2016-2021) (Kg)
Figure 28. Canada Paclitaxel Sales Growth Rate (2016-2021) (Kg)
Figure 29. Europe Paclitaxel Revenue Growth Rate 2016-2021 (Million US$)
Figure 30. Germany Paclitaxel Sales Growth Rate (2016-2021) (Kg)
Figure 31. France Paclitaxel Sales Growth Rate (2016-2021) (Kg)
Figure 32. U.K. Paclitaxel Sales Growth Rate (2016-2021) (Kg)
Figure 33. Italy Paclitaxel Sales Growth Rate (2016-2021) (Kg)
Figure 34. Russia Paclitaxel Sales Growth Rate (2016-2021) (Kg)
Figure 35. Asia Pacific Paclitaxel Revenue Growth Rate 2016-2021 (Million US$)
Figure 36. China Paclitaxel Sales Growth Rate (2016-2021) (Kg)
Figure 37. Japan Paclitaxel Sales Growth Rate (2016-2021) (Kg)
Figure 38. South Korea Paclitaxel Sales Growth Rate (2016-2021) (Kg)
Figure 39. India Paclitaxel Sales Growth Rate (2016-2021) (Kg)
Figure 40. Australia Paclitaxel Sales Growth Rate (2016-2021) (Kg)
Figure 41. Taiwan Paclitaxel Sales Growth Rate (2016-2021) (Kg)
Figure 42. Indonesia Paclitaxel Sales Growth Rate (2016-2021) (Kg)
Figure 43. Thailand Paclitaxel Sales Growth Rate (2016-2021) (Kg)
Figure 44. Malaysia Paclitaxel Sales Growth Rate (2016-2021) (Kg)
Figure 45. Philippines Paclitaxel Sales Growth Rate (2016-2021) (Kg)
Figure 46. Vietnam Paclitaxel Sales Growth Rate (2016-2021) (Kg)
Figure 47. Latin America Paclitaxel Revenue Growth Rate 2016-2021 (Million US$)
Figure 48. Mexico Paclitaxel Sales Growth Rate (2016-2021) (Kg)
Figure 49. Brazil Paclitaxel Sales Growth Rate (2016-2021) (Kg)
Figure 50. Argentina Paclitaxel Sales Growth Rate (2016-2021) (Kg)
Figure 51. Middle East and Africa Paclitaxel Revenue Growth Rate 2016-2021 (Million US$)
Figure 52. Turkey Paclitaxel Sales Growth Rate (2016-2021) (Kg)
Figure 53. Saudi Arabia Paclitaxel Sales Growth Rate (2016-2021) (Kg)
Figure 54. U.A.E Paclitaxel Sales Growth Rate (2016-2021) (Kg)
Figure 55. Phyton Total Revenue (US$ Million): 2020 Compared with 2018
Figure 56. ScinoPharm Total Revenue (US$ Million): 2020 Compared with 2018
Figure 57. Novasep Total Revenue (US$ Million): 2020 Compared with 2018
Figure 58. Samyang Total Revenue (US$ Million): 2020 Compared with 2018
Figure 59. Polymed Total Revenue (US$ Million): 2020 Compared with 2018
Figure 60. TAPI (Teva) Total Revenue (US$ Million): 2020 Compared with 2018
Figure 61. Fresenius-kabi Total Revenue (US$ Million): 2020 Compared with 2018
Figure 62. Huiang biopharma Total Revenue (US$ Million): 2020 Compared with 2018
Figure 63. Southpharma Total Revenue (US$ Million): 2020 Compared with 2018
Figure 64. Yunnan Hande Total Revenue (US$ Million): 2020 Compared with 2018
Figure 65. Hainan Yew Pharm Total Revenue (US$ Million): 2020 Compared with 2018
Figure 66. Jiangsu Yew Biotechnology Total Revenue (US$ Million): 2020 Compared with 2018
Figure 67. Paclitaxel Value Chain
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
Figure 70. North America Paclitaxel Sales Growth Rate Forecast (2021-2027) (Kg)
Figure 71. North America Paclitaxel Revenue Growth Rate Forecast (2021-2027) (US$ Million)
Figure 72. Europe Paclitaxel Sales Growth Rate Forecast (2021-2027) (Kg)
Figure 73. Europe Paclitaxel Revenue Growth Rate Forecast (2021-2027) (US$ Million)
Figure 74. Asia Pacific Paclitaxel Sales Growth Rate Forecast (2021-2027) (Kg)
Figure 75. Asia Pacific Paclitaxel Revenue Growth Rate Forecast (2021-2027) (US$ Million)
Figure 76. Latin America Paclitaxel Sales Growth Rate Forecast (2021-2027) (Kg)
Figure 77. Latin America Paclitaxel Revenue Growth Rate Forecast (2021-2027) (US$ Million)
Figure 78. Middle East and Africa Paclitaxel Sales Growth Rate Forecast (2021-2027) (Kg)
Figure 79. Middle East and Africa Paclitaxel Revenue Growth Rate Forecast (2021-2027) (US$ Million)
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed
Choose License Type
  • $4250  
  • $6250  
  • $8250  

Secure Payment


img1

Related Reports

Antibody Drug Conjugates Contract Manufacturing Market

Report Description According to the new market study, we provide a comprehensive and in-depth analys

Read More

Therapeutic Drug Monitoring Market

Report Description According to the new market study, we provide a comprehensive and in-depth analys

Read More

Topical Drug Delivery System Market

Report Description According to the new market study, we provide a comprehensive and in-depth analys

Read More